149 related articles for article (PubMed ID: 31452738)
21. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
23. How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.
Poortahmasebi V; Poorebrahim M; Najafi S; Jazayeri SM; Alavian SM; Arab SS; Ghavami S; Alavian SE; Rezaei Moghadam A; Amiri M
Hepat Mon; 2016 Feb; 16(2):e36005. PubMed ID: 27148389
[TBL] [Abstract][Full Text] [Related]
24. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
Cai C; Wang W; Tu Z
J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
[No Abstract] [Full Text] [Related]
25. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
26. Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma.
Sha M; Cao J; Zong ZP; Xu N; Zhang JJ; Tong Y; Xia Q
Ann Transl Med; 2021 Jun; 9(12):975. PubMed ID: 34277775
[TBL] [Abstract][Full Text] [Related]
27. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
28. Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis.
Xing T; Yan T; Zhou Q
Exp Ther Med; 2018 Jun; 15(6):4932-4942. PubMed ID: 29805517
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential key genes and pathways in hepatitis B virus-associated hepatocellular carcinoma by bioinformatics analyses.
Zhang X; Wang L; Yan Y
Oncol Lett; 2020 May; 19(5):3477-3486. PubMed ID: 32269621
[TBL] [Abstract][Full Text] [Related]
30. Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
Xu L; Tong T; Wang Z; Qiang Y; Ma F; Ma X
Am J Med Sci; 2020 Apr; 359(4):226-234. PubMed ID: 32200915
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
[TBL] [Abstract][Full Text] [Related]
32. Examining the biomarkers and molecular mechanisms of medulloblastoma based on bioinformatics analysis.
Yang B; Dai JX; Pan YB; Ma YB; Chu SH
Oncol Lett; 2019 Jul; 18(1):433-441. PubMed ID: 31289514
[TBL] [Abstract][Full Text] [Related]
33. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
[TBL] [Abstract][Full Text] [Related]
34. Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
Li R; Wang L; Wang X; Geng RX; Li N; Liu XH
Oncol Lett; 2020 Apr; 19(4):2846-2860. PubMed ID: 32218839
[TBL] [Abstract][Full Text] [Related]
35. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
36. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
37. Screening therapeutic targets of ribavirin in hepatocellular carcinoma.
Xu C; Luo L; Yu Y; Zhang Z; Zhang Y; Li H; Cheng Y; Qin H; Zhang X; Ma H; Li Y
Oncol Lett; 2018 Jun; 15(6):9625-9632. PubMed ID: 29805683
[TBL] [Abstract][Full Text] [Related]
38. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
39. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
Cheng Y; Ping J; Chen J
Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
[TBL] [Abstract][Full Text] [Related]
40. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
Shi Y; Li Y; Yan C; Su H; Ying K
Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
